Drugmakers said President Joe Biden's support for waiving patents of COVID -19 vaccines could disrupt a fragile supply chain and that rich countries should instead share more generously with the developing world
Drugmakers on Thursday said U.S. President Joe Biden's support for waiving patents of COVID -19 vaccines could disrupt a fragile supply chain and that rich countries should instead share more generously with the developing world.
Another German company CureVac, which hopes to release trial results on its messenger ribonucleic acid (mRNA) vaccine as early as this month, said patents were not to blame for supply bottlenecks.1/2U.S. President Joe Biden puts his hand on a man's shoulder during a visit to a coronavirus disease (COVID-19) vaccination site at Virginia Theological Seminary in Alexandria, Virginia, U.S., April 6, 2021. REUTERS/Kevin Lamarque/File Photo
Read More"Since mRNA technology has emerged as the key technology in the fight against COVID-19, the world now needs the same raw materials in unfathomable amounts. The biggest problem is how to coordinate this," a spokeswoman said.IFPMA's Cueni said the real bottlenecks were trade barriers, in particular the U.S. Defense Production Act (DPA).
The DPA is a decades-old U.S. law that prioritised procurement orders related to U.S. national defence, but it has been widely used in non-military crises, such as natural disasters.Cueni said the way to kickstart low-income countries' vaccination campaigns was for rich countries to donate vaccine, rather than widen eligibility to young and healthy people at home. headtopics.com
Moderna(MRNA.O), which on Thursday reported quarterly results, said waiving intellectual property rights would not help to increase supply of its vaccines in 2021 and 2022.The U.S. drugmaker said last year it would not enforce its vaccine patents. CureVac said on Thursday it would also not enforce its patents during the pandemic and that it knew of no other developer that would.
Italy's ReiThera which is in late-stage tests on an experimental COVID-19 vaccine, was also critical of patent waivers."There is proprietary know-how that has to be transferred by the owner. And then there is the problem with process materials, which at the moment have delivery times of almost a year," ReiThera's chief of technology Stefano Colloca said.Read more: Reuters Top News »
8-year-old boy sells Pokémon cards to help sick dog - CNN Video
CNN News, delivered. Select from our newsletters below and enter your email to subscribe.
Wow, crazy that the drugmakers investigated themselves and found that whatever makes them the most money is the best thing for the world 🤦🏾♀️ Yes, rich countries should just do the right thing and share more Corporations should just do the right thing and pay employees living wages and not destroy the environment Rich people should just pay more in taxes because it's the right thing for everyone Mmmhmmmm